Frost & Sullivan Unfolds the Future of the US Medical Imaging Industry


Reading time ( words)

Frost & Sullivan, the growth partnership company, announced today that it will host a live, complimentary Growth Innovation Leadership (GIL) briefing titled, "The Future of the United States Medical Imaging Industry," on Tuesday, January 23, 2018, from 11:00 AM to 12:00 PM Eastern Time. The webinar will offer expert insight from Tanvir Jaikishen, Frost & Sullivan's Transformatinal Health Senior Research Analyst.

The U.S. medical imaging industry is transforming as it faces a host of regulatory and reimbursement challenges along with stagnant imaging procedure volumes. The resulting increased emphasis on demonstrable improvements in quality of care and cost savings, coupled with deep Medicare reimbursement cuts, have forced stakholders across the imaging ecosystem to enhance levels of collaboration in order to make the imaging process more patient-friendly and efficient.

Mirroring the current trends of the U.S. health system as a whole, the imaging industry seeks to move away from episodic care management to population health approaches. In order to achieve this goal, interoperability across a highly fragmented imaging provider landscape must be enhanced. In addition, a more efficient and more accurate imaging workflow is essential through the application of cloud computing, artificial intelligence and personalized medicine.

“Under MACRA payments, 85 percent of the reimbursements for radiologists will be quality based,” noted Jaikishen. “Moreover, the coming years will see a major transformation in the role of radiologists, from that of a passive stakeholder to a role that is deeply integrated throughout the entire patient care pathway.”

The webinar will provide expert insight on how imaging original equipment manufacturers (OEMs) and imaging care providers are increasingly working together to provide future ready solutions to address the myriad challenges of the imaging industry. Furthermore, it will guide you through the evolution of long-term vendor-customer partnerships.

Expert Insight You Will Not Want to Miss:

  • The current US medical imaging ecosystem, its inherent challenges, and how stakeholders are working together to make it more efficient
  • Unmet needs in the industry and how OEMs and other imaging forms are working with care providers to address these needs
  • Exciting future opportunities in imaging, which go beyond big data analytics and population health management

How to focus more on using the data to bring about standardization of the imaging, Image interpretation process, improving the patient experience, and making smarter long-term procurement decisions

  • The evolving role of the radiologist, challenges faced, and how the industry is helping them play a more direct role in the patient outcomes process

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion

Share


Suggested Items

Today’s MilAero Options, Part 1: 'Pride Goeth Before...'

04/12/2016 | Marc Carter
Historians, with their 20/20 hindsight, often write about the inevitable decline and fall of kingdoms, empires, religions, organizations, governments, and all the other permanent structures we humans build.

Wearable Tech Back to a Healthy Development Pace

02/11/2015 | Reed Exhibitions
Wearable tech was a major sensation in 2014. The wearable tech industry generated extensive interest among media, investors, start-ups, wearable tech enthusiasts, technology leaders and trade fairs. Many events were held around wearable products and industry last year. The trend for early 2015 has seen the industry fall back into a healthy developmental pace. Investors are keen to see a return on their capital injections and former start-ups are now reaching maturity.



Copyright © 2018 I-Connect007. All rights reserved.